Endocrine Abstracts

Context: Little research has been performed on hemostatic changes in transgender subjects receiving cross-sex hormone treatment (CSHT), despite the fact that several studies implicate an increased risk of venous thrombosis (VT) associated with hormones.Objective: Assessing whether coagulation is relevantly influenced by prolonged CSHT, stratified for the different treatment modalities, in transgenders.Design and main outcome: Prosp...